Tell Your Congressmember to Co-Sponsor the Pandemic Treatment Access & Affordability Act
Representatives Ashley Hinson, Mariannette Miller-Meeks, Cindy Axne, & Randy Feenstra
The Pandemic Treatment Access and Affordability Act of 2021 establishes comprehensive protections against price gouging for COVID-19 treatments and vaccines by:
- Prohibiting pharmaceutical monopolies on new, taxpayer-funded COVID-19 drugs in order to ensure universal access to these drugs;
- Requiring the federal government to mandate reasonable, affordable pricing of any new, taxpayer-funded COVID-19 drug used to diagnose, mitigate, prevent, or treat COVID-19
- Ensuring transparency and requiring manufacturers to publicly report a specific breakdown of total expenditures on any COVID-19 drug, including what percentage of those expenditures were derived from federal funds; and
- Preventing excessive pricing of drug used to treat any disease that causes a public health emergency by waiving exclusive licenses and compensating with a reasonable royalty.
Sponsored by
To:
Representatives Ashley Hinson, Mariannette Miller-Meeks, Cindy Axne, & Randy Feenstra
From:
[Your Name]
We are asking our members of Congress to co-sponsor the Pandemic Treatment Access and Affordability ACT that will protect against pandemic profiteering and guarantee every person affordable access to COVID-19 treatments and vaccines developed with taxpayer dollars.
No prescription drug corporation should be given monopoly control over prices
In order to fight this pandemic, we need sufficient quantities to ensure universal access to safe, affordable treatments and vaccines.
We deserve transparency, including how much taxpayers have contributed and corporations’ costs of production.
That is why we ask for your co-sponsorship of the Pandemic Treatment Access & Affordability Act (PTAA) Act.